Exchange: NASDAQ·Updated 04:00 AM EDT
EIKN logo

EIKN Eikon Therapeutics Inc.

$12.32
$0.34
(2.84%)
Pre-Market
Prev Close $11.98
Reported EarningsAug 13
Mkt Cap$679.77M
Vol1,687.00

About EIKN

Eikon Therapeutics is a biopharmaceutical company. It engages in the development of medicines for unmet medical needs. The company was founded in 2019 and is headquartered in Millbrae, CA.
52

Neutral Sentiment

How do you feel about EIKN?

Advertisement|Remove ads.